FIGO staging was as follows: Stage I, n = 18; stage II, n = 2; stage III, n = 8.
The overall distribution of pelvic organ prolapse quantification system stages was as follows: stage 0, 6.4%; stage 1, 43.3%; stage 2, 47.7%; and stage 3, 2.6%.
The Drumian Stage follows Stage 5 and precedes the Guzhangian Stage, all three stages making up Series 3 of the Cambrian System.
The stage distribution of these ovarian cancers at diagnosis was as follows: stage IIB (1), stage IIC (6), stage IIIB (1), stage IIIC (54) and stage IV (17).
The score of each hair morphogenesis stage was defined as follows: stage 1 = 1, stage 2 = 2, stage 3 = 3, stage 4 = 4, stage 5 = 5, stage 6 = 6, stage 7 = 7, and stage 8 = 8.
The gross duration of incubation described in Ballard et al. (1993) was as follows: stage 27 (42 46 days), stage 29 (49 53 days), stage 32 (75–125 days).
The proportions of children in each CKD stage were as follows: stage 1: 50%; stages 2-4: 30%; stage 5: 20%.
Disease stages were as follows: stage I: 14.4%, stage II: 59.9%, stage III: 20% and stage IV: 5.7%.
Presumed stage was as follows: stage I, n=107; stage II, n=13; stage III, n=29; and stage IV, n=22.
The disease stage distribution was as follows: stage I, 1 (2.9%); stage III, 14 (41.2%); and stage IV, 19 (55.9%).
